Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Lisa D Earnhardt. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Lisa D Earnhardt har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:ABT / Abbott Laboratories EVP AND GROUP PRESIDENT 71 928
US:XENT / Intersect ENT Inc Director 48 333
US:NVRO / Nevro Corp. Director 5 303
US:KNSY / Kensey Nash Corp Director 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Lisa D Earnhardt. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Lisa D Earnhardt som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-03-07 2025-03-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −200 71 928 −0,28 136,64 −27 329 9 828 602
2025-03-07 2025-03-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 200 72 128 0,28 80,98 16 196 5 840 925
2025-03-07 2025-03-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −91 167 71 928 −55,90 133,82 −12 199 968 9 625 405
2025-03-07 2025-03-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 91 167 163 095 126,75 80,98 7 382 704 13 207 433
2025-03-04 2025-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −8 322 71 928 −10,37 135,87 −1 130 710 9 772 857
2025-02-27 2025-02-25 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18 788 80 250 30,57
2024-05-08 2024-05-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −22 852 61 462 −27,10 106,25 −2 428 119 6 530 589
2024-03-04 2024-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −694 84 314 −0,82 118,50 −82 239 9 991 209
2024-03-04 2024-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −7 669 85 008 −8,27 120,05 −920 663 10 205 210
2024-02-23 2024-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17 240 92 677 22,85
2023-03-02 2023-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −943 75 437 −1,23 100,70 −94 960 7 596 506
2023-03-02 2023-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −7 631 76 380 −9,08 99,77 −761 345 7 620 433
2023-02-22 2023-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 15 855 84 011 23,26
2022-06-14 2022-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −19 592 68 156 −22,33 112,71 −2 208 214 7 681 863
2022-06-14 2022-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −2 882 87 748 −3,18 112,71 −324 830 9 890 077
2022-03-02 2022-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −943 90 630 −1,03 118,15 −111 416 10 707 962
2022-03-02 2022-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −5 168 91 573 −5,34 122,41 −632 615 11 209 451
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 80 380 80 380
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17 247 96 741 21,70
2021-06-11 2021-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −2 881 79 494 −3,50 109,05 −314 173 8 668 821
2021-03-02 2021-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −943 82 375 −1,13 120,61 −113 735 9 935 249
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −2 621 83 318 −3,05 121,58 −318 661 10 129 802
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 71 070 71 070
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 13 865 85 939 19,24
2020-06-12 2020-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale −872 72 074 −1,20 90,84 −79 216 6 547 490
2020-06-12 2020-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes −2 855 72 946 −3,77 90,27 −257 721 6 584 835
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 114 940 114 940
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 18 855 75 801 33,11
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 48 333 48 333
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer −48 333 0 −100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 45 500 45 500
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer −45 500 0 −100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 196 875 196 875
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer −196 875 0 −100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 150 000 150 000
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer −150 000 0 −100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 19 688 19 688
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
D - Sale to Issuer −19 688 0 −100,00
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
A - Award 44 625 44 625
2019-07-26 2019-07-24 4 XENT Intersect ENT, Inc.
Stock Option (Right to buy)
D - Sale to Issuer −44 625 0 −100,00
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 91 367 91 367
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 39 515 56 946 226,69
2019-06-12 2019-06-10 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 17 431 17 431
2019-06-12 3 ABT ABBOTT LABORATORIES
Common shares without par value
0
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −9 500 140 000 −6,35
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −9 500 421 983 −2,20 25,59 −243 102 10 798 418
2019-05-17 2019-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 9 500 431 483 2,25 13,05 123 975 5 630 853
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −6 016 48 333 −11,07
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −7 500 149 500 −4,78
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −29 588 421 983 −6,55 28,43 −841 243 11 997 778
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 6 016 451 571 1,35 1,20 7 219 541 885
2019-04-17 2019-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 7 500 445 555 1,71 13,05 97 875 5 814 493
2019-01-18 2019-01-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 157 500 157 500
2019-01-18 2019-01-16 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 33 800 438 055 8,36
2019-01-03 2019-01-01 4 XENT Intersect ENT, Inc.
Common Stock
F - Taxes −10 428 404 255 −2,51 26,57 −277 046 10 740 045
2018-12-26 2018-12-20 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −35 000 54 349 −39,17
2018-12-26 2018-12-20 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 35 000 414 683 9,22 1,20 42 000 497 620
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 157 000 −3,09
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 379 683 −5,00 29,73 −594 504 11 286 153
2018-12-19 2018-12-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 399 683 1,27 13,05 65 250 5 215 863
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 162 000 −2,99
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 394 683 −4,82 30,01 −600 296 11 846 331
2018-11-19 2018-11-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 414 683 1,22 13,05 65 250 5 411 613
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 167 000 −2,91
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 409 683 −4,65 29,63 −592 614 12 139 194
2018-10-17 2018-10-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 429 683 1,18 13,05 65 250 5 607 363
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 172 000 −2,82
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 424 683 −4,50 29,14 −582 862 12 376 579
2018-09-19 2018-09-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 444 683 1,14 13,05 65 250 5 803 113
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 177 000 −2,75
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 439 683 −4,35 26,51 −530 194 11 655 864
2018-08-17 2018-08-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 459 683 1,10 13,05 65 250 5 998 863
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 182 000 −2,67
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 454 683 −4,21 33,08 −661 686 15 042 869
2018-07-18 2018-07-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 474 683 1,06 13,05 65 250 6 194 613
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −5 000 187 000 −2,60
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 469 683 −4,08 36,79 −735 710 17 277 524
2018-06-19 2018-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 5 000 489 683 1,03 13,05 65 250 6 390 363
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3 785 5 303 249,34
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −15 000 192 000 −7,25
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −15 000 484 683 −3,00 39,22 −588 244 19 007 474
2018-05-17 2018-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15 000 499 683 3,09 13,05 195 750 6 520 863
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −15 000 207 000 −6,76
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −15 000 484 683 −3,00 39,59 −593 918 19 190 781
2018-04-17 2018-04-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15 000 499 683 3,09 13,05 195 750 6 520 863
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −15 000 222 000 −6,33
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −15 000 484 683 −3,00 38,32 −574 791 18 572 762
2018-03-16 2018-03-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15 000 499 683 3,09 13,05 195 750 6 520 863
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −15 000 237 000 −5,95
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −15 000 484 683 −3,00 36,40 −545 938 17 640 474
2018-02-16 2018-02-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 15 000 499 683 3,09 13,05 195 750 6 520 863
2018-01-19 2018-01-18 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −11 166 484 683 −2,25 33,47 −373 695 16 220 983
2018-01-19 2018-01-17 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 119 000 119 000
2018-01-19 2018-01-17 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 25 500 495 849 5,42
2018-01-03 2018-01-01 4 XENT Intersect ENT, Inc.
Common Stock
F - Taxes −6 834 470 349 −1,43 33,93 −231 897 15 960 259
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −2 000 6 016 −24,95
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −10 685 477 183 −2,19 31,87 −340 512 15 206 963
2017-12-18 2017-12-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 2 000 487 868 0,41 1,20 2 400 585 442
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 8 016 −55,51
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 485 868 −3,95 27,88 −557 620 13 546 486
2017-11-17 2017-11-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 505 868 2,02 1,20 12 000 607 042
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 18 016 −35,69
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 495 868 −3,88 28,37 −567 336 14 066 188
2017-10-17 2017-10-16 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 515 868 1,98 1,20 12 000 619 042
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 28 016 −26,30
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 505 868 −3,80 30,19 −603 870 15 273 925
2017-09-19 2017-09-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 525 868 1,94 1,20 12 000 631 042
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 38 016 −20,83
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 515 868 −3,73 30,79 −615 810 15 883 834
2017-08-17 2017-08-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 535 868 1,90 1,20 12 000 643 042
2017-08-17 2017-08-09 4 XENT Intersect ENT, Inc.
Common Stock
G - Gift −35 000 525 868 −6,24
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 48 016 −17,24
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 560 868 −3,44 29,03 −580 642 16 283 176
2017-07-18 2017-07-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 580 868 1,75 1,20 12 000 697 042
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −2 625 58 016 −4,33
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −7 375 0 −100,00
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 570 868 −3,38 26,10 −521 978 14 899 027
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 7 375 590 868 1,26 1,20 8 850 709 042
2017-06-19 2017-06-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 2 625 583 493 0,45 1,20 3 150 700 192
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3 545 3 545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1 518 1 518
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 7 375 −57,55
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 580 868 −3,33 22,98 −459 520 13 346 023
2017-05-16 2017-05-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 600 868 1,69 1,20 12 000 721 042
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 17 375 −36,53
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 590 868 −3,27 16,06 −321 244 9 490 640
2017-04-18 2017-04-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 610 868 1,66 1,20 12 000 733 042
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −10 000 27 375 −26,76
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −10 000 600 868 −1,64 15,02 −150 188 9 024 316
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −10 000 610 868 −1,61 15,03 −150 265 9 179 208
2017-03-16 2017-03-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 10 000 620 868 1,64 1,20 12 000 745 042
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −20 000 37 375 −34,86
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 610 868 −3,17 13,01 −260 170 7 946 476
2017-02-17 2017-02-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 20 000 630 868 3,27 1,20 24 000 757 042
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 252 000 252 000
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 54 000 610 868 9,70
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
M - Exercise −400 56 975 −0,70
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −400 556 868 −0,07 18,00 −7 200 10 023 624
2016-10-19 2016-10-17 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 400 557 268 0,07 1,20 480 668 722
2016-05-20 2016-05-18 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3 240 3 240
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −4 000 57 375 −6,52
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −8 500 556 868 −1,50 19,50 −165 740 10 858 258
2016-04-19 2016-04-18 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 4 000 565 368 0,71 1,20 4 800 678 442
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −20 000 61 375 −24,58
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −20 000 561 368 −3,44 18,34 −366 848 10 296 836
2016-04-19 2016-04-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 20 000 581 368 3,56 1,20 24 000 697 642
2016-03-16 2016-03-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −9 000 561 368 −1,58 18,01 −162 084 10 109 845
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 225 000 225 000
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
M - Exercise −8 000 81 375 −8,95
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −12 500 570 368 −2,14 19,26 −240 808 10 987 911
2016-01-20 2016-01-15 4 XENT Intersect ENT, Inc.
Common Stock
M - Exercise 8 000 582 868 1,39 1,20 9 600 699 442
2015-12-16 2015-12-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −6 820 574 868 −1,17 19,85 −135 408 11 413 717
2015-11-17 2015-11-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −6 818 581 688 −1,16 18,00 −122 732 10 471 082
2015-10-16 2015-10-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −6 818 588 506 −1,15 18,72 −127 619 11 015 655
2015-09-16 2015-09-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −6 818 595 324 −1,13 25,99 −177 229 15 475 031
2015-08-19 2015-08-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −6 818 602 142 −1,12 28,51 −194 385 17 167 369
2015-07-16 2015-07-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −19 318 608 960 −3,07 29,62 −572 153 18 035 934
2015-07-01 2015-06-29 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 5 853 5 853
2015-06-16 2015-06-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −19 318 628 278 −2,98 29,30 −565 992 18 407 729
2015-05-19 2015-05-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −19 318 647 596 −2,90 23,69 −457 628 15 341 031
2015-04-17 2015-04-15 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −19 318 666 914 −2,82 25,96 −501 544 17 314 755
2015-03-18 2015-03-16 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −19 318 686 232 −2,74 23,56 −455 057 16 164 950
2015-02-19 2015-02-17 4 XENT Intersect ENT, Inc.
Common Stock
S - Sale X −19 318 705 550 −2,67 22,69 −438 343 16 009 564
2015-01-23 2015-01-21 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 150 000 150 000
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
1 475 918
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
777 232
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
1 475 918
2014-07-23 3 XENT Intersect ENT, Inc.
Common Stock
777 232
2012-06-26 2012-06-22 4 KNSY KENSEY NASH CORP
Common Stock
D - Sale to Issuer −5 100 0 −100,00 38,50 −196 350
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)